SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (227)7/27/1998 2:14:00 PM
From: scaram(o)ucheRead Replies (2) | Respond to of 4974
 
more venting about the Informed Investors forum......

The "spin" came from individuals that can't conceive of the concept that valuation should be determined by the quality of science rather than by the degree of coverage. It came from people that would condemn a company for the price of its stock.

Let's slowly put the mechanism in place to change that.

Again, the II meeting was excellent. Highly recommended.



To: scaram(o)uche who wrote (227)7/30/1998 1:17:00 AM
From: scaram(o)ucheRead Replies (1) | Respond to of 4974
 
>> SUGN.... the indication was that intl. license deals are imminent. <<

Talk about good timing (thanks, PB)......

Sugen Plans To Unveil $70M Pact With Taiho Thursday
By MARK BOSLET
Dow Jones Newswires

PALO ALTO, Calif., -- Sugen Inc. (SUGN) plans on Thursday to announce a
multi-million-dollar development and marketing pact with Taiho
Pharmaceutical Co. of Japan. (snip)